HU229307B1 - Carboxylic acid derivatives that inhibit the binding of integrins to their receptors - Google Patents

Carboxylic acid derivatives that inhibit the binding of integrins to their receptors Download PDF

Info

Publication number
HU229307B1
HU229307B1 HU0201539A HUP0201539A HU229307B1 HU 229307 B1 HU229307 B1 HU 229307B1 HU 0201539 A HU0201539 A HU 0201539A HU P0201539 A HUP0201539 A HU P0201539A HU 229307 B1 HU229307 B1 HU 229307B1
Authority
HU
Hungary
Prior art keywords
oxo
alkyl
methyl
acid
group
Prior art date
Application number
HU0201539A
Other languages
English (en)
Hungarian (hu)
Inventor
Ronald J Biediger
Qi Chen
George William Holland
Jamal M Kassir
Wen Li
Robert V Market
Ian L Scott
Chengde Wu
Original Assignee
Encysive Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Encysive Pharmaceuticals Inc filed Critical Encysive Pharmaceuticals Inc
Priority claimed from PCT/US2000/012303 external-priority patent/WO2000067746A1/en
Publication of HUP0201539A2 publication Critical patent/HUP0201539A2/hu
Publication of HUP0201539A3 publication Critical patent/HUP0201539A3/hu
Publication of HU229307B1 publication Critical patent/HU229307B1/hu

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/75Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/47One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
HU0201539A 1999-05-07 2000-05-05 Carboxylic acid derivatives that inhibit the binding of integrins to their receptors HU229307B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13219799P 1999-05-07 1999-05-07
PCT/US2000/012303 WO2000067746A1 (en) 1999-05-07 2000-05-05 Carboxylic acid derivatives that inhibit the binding of integrins to their receptors

Publications (3)

Publication Number Publication Date
HUP0201539A2 HUP0201539A2 (en) 2002-08-28
HUP0201539A3 HUP0201539A3 (en) 2003-07-28
HU229307B1 true HU229307B1 (en) 2013-10-28

Family

ID=22452921

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0201539A HU229307B1 (en) 1999-05-07 2000-05-05 Carboxylic acid derivatives that inhibit the binding of integrins to their receptors

Country Status (5)

Country Link
KR (1) KR100853950B1 (zh)
CN (1) CN1292744C (zh)
BR (1) BR0010293B1 (zh)
HU (1) HU229307B1 (zh)
PT (1) PT1176956E (zh)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8586604B2 (en) * 2010-08-20 2013-11-19 Boehringer Ingelheim International Gmbh Inhibitors of the microsomal prostaglandin E2 synthase-1

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5770573A (en) * 1993-12-06 1998-06-23 Cytel Corporation CS-1 peptidomimetics, compositions and methods of using the same

Also Published As

Publication number Publication date
BR0010293B1 (pt) 2011-09-20
PT1176956E (pt) 2008-04-17
CN1360498A (zh) 2002-07-24
HUP0201539A3 (en) 2003-07-28
BR0010293A (pt) 2002-07-16
KR100853950B1 (ko) 2008-08-25
KR20020009607A (ko) 2002-02-01
HUP0201539A2 (en) 2002-08-28
CN1292744C (zh) 2007-01-03

Similar Documents

Publication Publication Date Title
ES2379945T3 (es) Derivados de ácido carboxílico que inhiben la unión de integrinas a sus receptores
RU2263109C2 (ru) ПРОИЗВОДНЫЕ КАРБОНОВЫХ КИСЛОТ (ВАРИАНТЫ), ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ И СПОСОБ СЕЛЕКТИВНОГО ИНГИБИРОВАНИЯ СВЯЗЫВАНИЯ α4β1 ИНТЕГРИНА У МЛЕКОПИТАЮЩЕГО
AU2002219555B2 (en) VLA-4 Inhibitors
EP1079825B1 (en) Compounds that inhibit the binding of integrins to their receptors
US8586755B2 (en) Substituted nicotinamides as KCNQ2/3 modulators
BG63628B1 (bg) Заместени (сулфинова киселина, сулфонова киселина, сулфониламино или сулфиниламино) n-[(аминоиминометил) фенилалкил]-азахетероциклиламидни съединения
KR100767199B1 (ko) 인테그린이 이의 수용체에 결합하는 것을 억제하는프로판산 유도체
NO314758B1 (no) Substituerte N-[(aminiminmetyl- eller aminmetyl)fenyl]- propylamider
AU2005288080A1 (en) Carbostyril compound
IE83508B1 (en) Quinoxalines, processes for their preparation, and their use
CZ293825B6 (cs) ChinoxalinyŹ způsob jejich výroby a jejich použití a farmaceutické prostředky tyto látky obsahující
CA3083616A1 (en) Myst family histone acetyltransferase inhibitors
US5633379A (en) 3-heteroaliphatyl- and 3-hetero(aryl)aliphatyl-2(1H)-quinolone derivatives
US5459152A (en) Platelet activating factor antagonists
HU229307B1 (en) Carboxylic acid derivatives that inhibit the binding of integrins to their receptors
SI21096A1 (sl) Derivati karboksilne kisline, ki inhibirajo vezavo integrinov na njihove receptorje
JP2003508516A (ja) ビトロネクチン受容体アンタゴニスト
CA3152923A1 (en) Bet degrader
CZ2000293A3 (cs) Heterocyklické deriváty, které inhibují faktor Xa

Legal Events

Date Code Title Description
FD9A Lapse of provisional protection due to non-payment of fees
NF4A Restoration of patent protection
HC9A Change of name, address

Owner name: ENCYSIVE PHARMACEUTICALS INC., US

Free format text: FORMER OWNER(S): TEXAS BIOTECHNOLOGY CORPORATION, US

TH4A Erratum
MM4A Lapse of definitive patent protection due to non-payment of fees